University of Rochester
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Rochester sits in the top decile of US sponsors by registered trial count (#53 of 15,742 sponsors by registered trial count).
University of Rochester: 636 sponsored US clinical trials, 94 recruiting.
University of Rochester sponsors 636 registered US clinical trials on ClinicalTrials.gov, 94 of them currently recruiting, and 448 completed. 54 of these trials are in Phase 3-4 (later-stage) and 147 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cancer, with 7 trials.
Top-decile sponsor footprint
University of Rochester ranks in the top decile of sponsors by registered trial count (#53 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
448 of 506 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
636 total, page 13 of 13
Trial of Mifepristone for Fibroids
NCT00133705
National Institute of Neurological Disorders and Stroke (NINDS) Parkinson's Disease Neuroprotection Trial
NCT00063193
Comparison of Two Psychotherapy Treatments for Depressed Women With a History of Sexual Abuse
NCT00257400
Maternal Problem-Solving in Childhood Cancer
NCT00234793
Emergency Linkage to Outpatient Psychiatric Services
NCT00278811
Improving Outcomes of Hospitalized Elders and Caregivers
NCT00178412
Escitalopram Treatment of Patients With Agitated Dementia
NCT00260624
Prehospital Screening to Prevent Injury and Illness
NCT00382655
Improving Asthma Care for Very Low Birth Weight Infants
NCT00156507
Buspirone in Reducing Shortness of Breath in Patients With Cancer
NCT00053846
Vulvar Vestibulitis Clinical Trial: Desipramine-Lidocaine
NCT00276068
Music Therapy During Botulinum Injections
NCT00178217
Gabapentin Versus Estrogen for the Treatment of Hot Flashes
NCT00276081
Trial of Chemotherapy Followed by Pulsed Docetaxel and Concurrent Radiation for Non-Small Cell Lung Cancer
NCT00167401
The Long Term Impact of Initiating Pramipexole Versus Levodopa in Early Parkinson's Disease (CALM-PD Cohort Study)
NCT00804479
Study of Breath-holding as a Means to Reduce Tumor Motion From Breathing
NCT00178477
Omega-3 Fatty Acids in Children and Adolescents With Bipolar Disorder
NCT00252486
Educational/Behavioral Intervention Program for Parents of Premature Infants
NCT00120614
Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer
NCT00262886
A Study For Using Radiosurgery On Limited Metastases
NCT00178399
Neural Changes in the Aging Auditory System
NCT00264407
Health-e-Access Telemedicine in Primary Pediatric Care
NCT00234806
Study for Using Radiosurgery on Limited Metastases of Breast Cancer
NCT00167414
Patient Education in Preventing Nausea and Vomiting in Cancer Patients Receiving Chemotherapy
NCT00005994
Conditioning, the Placebo Effect, and Psoriasis
NCT00005922
Radiation-Induced Cytokine Cascades and Their Correlation With Central Nervous System Injury
NCT00178295
Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate Cancer
NCT00003903
Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors
NCT00004016
Pulsed Paclitaxel And Daily Thoracic Radiotherapy For Inoperable (Stage I/II) Or Unresectable Lung Cancer
NCT00178256
Rituximab Plus Interleukin-2 in Treating Patients With Lymphoma
NCT00003356
In Home Hospital Care Program
NCT00234780
Circulating Cytokines as Predictors of Radiation Induced Pulmonary Toxicity
NCT00178230
Long QT Syndrome-Population Genetics and Cardiac Studies
NCT00005176
Feasibility of Treatment of Cancer Involving the Liver With High Dose Radiation
NCT00178243
Parallel Group, Placebo-Controlled, Tolerability, Safety, and Efficacy Study of OPC-14117 in HIV Dementia
NCT00002148
Measuring Alterations of DNA in Human Blood
NCT00178308
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 66 |
| Phase 2 | 81 |
| Phase 3 | 20 |
| Phase 4 | 34 |
Therapeutic Areas
What is open in the University of Rochester pipeline
94 recruiting of 636 indexed (15% open); 448 completed (70%).
Phase mix: 54 late (III/IV) vs 147 early (I/II) (early-phase heavy).
Top condition: Cancer (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Rochester: open-pipeline peers nationwide
Peers matched on 636 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Rochester sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 636 trials (± recruiting share)
- US Department of Veterans Affairs · 632 trials · 0% recruiting
- University of Southern California · 617 trials · 16% recruiting
- Baylor College of Medicine · 616 trials · 15% recruiting
- University of California, Davis · 657 trials · 19% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Loma Linda University · 15% recruiting · 237 trials
- Dompé Farmaceutici S.p.A · 15% recruiting · 27 trials
- Vanderbilt-Ingram Cancer Center · 15% recruiting · 189 trials
- Brown University · 15% recruiting · 231 trials
Related
What to do with this University of Rochester page
636 registered trials is a research-attention snapshot, not an endorsement of University of Rochester or any single study.
- 94 of University of Rochester's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Cancer is the condition University of Rochester studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Rochester pipeline card: 636 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.